17-81809063-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_000160.5(GCGR):c.45G>A(p.Leu15Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000293 in 1,535,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
GCGR
NM_000160.5 synonymous
NM_000160.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.29
Genes affected
GCGR (HGNC:4192): (glucagon receptor) The protein encoded by this gene is a glucagon receptor that is important in controlling blood glucose levels. Defects in this gene are a cause of non-insulin-dependent diabetes mellitus (NIDDM).[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 17-81809063-G-A is Benign according to our data. Variant chr17-81809063-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1904240.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.29 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCGR | NM_000160.5 | c.45G>A | p.Leu15Leu | synonymous_variant | 2/14 | ENST00000400723.8 | NP_000151.1 | |
GCGR | XM_006722277.2 | c.45G>A | p.Leu15Leu | synonymous_variant | 2/14 | XP_006722340.1 | ||
GCGR | XM_017024446.2 | c.45G>A | p.Leu15Leu | synonymous_variant | 2/14 | XP_016879935.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCGR | ENST00000400723.8 | c.45G>A | p.Leu15Leu | synonymous_variant | 2/14 | 1 | NM_000160.5 | ENSP00000383558.3 | ||
GCGR | ENST00000572185.1 | n.340G>A | non_coding_transcript_exon_variant | 2/3 | 1 | |||||
GCGR | ENST00000570996.5 | c.45G>A | p.Leu15Leu | synonymous_variant | 2/12 | 2 | ENSP00000460976.1 | |||
GCGR | ENST00000573428.1 | c.45G>A | p.Leu15Leu | synonymous_variant | 2/4 | 4 | ENSP00000458930.1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152230Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
29
AN:
152230
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000145 AC: 2AN: 138204Hom.: 0 AF XY: 0.0000135 AC XY: 1AN XY: 74062
GnomAD3 exomes
AF:
AC:
2
AN:
138204
Hom.:
AF XY:
AC XY:
1
AN XY:
74062
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000116 AC: 16AN: 1383746Hom.: 0 Cov.: 32 AF XY: 0.00000879 AC XY: 6AN XY: 682766
GnomAD4 exome
AF:
AC:
16
AN:
1383746
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
682766
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000191 AC: 29AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74368
GnomAD4 genome
AF:
AC:
29
AN:
152230
Hom.:
Cov.:
32
AF XY:
AC XY:
17
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 14, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at